- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT03558256
The Study of Mindfulness-based Cognitive Therapy and Major Depressive Disorder
The primary objective of the study is to evaluate the clinical curative effect of mindfulness-based cognitive therapy(MBCT) for major depressive disorder(MDD). Moreover, we will also explore the relationship between P300 potential and erroneous negative potential (ERN) variation and clinical symptoms in MDD and MBCT.
This study is a randomized-control trial with two study arms: half of patient cases will receive usual medication treatment with the serotonin reuptake inhibitors (SSRIs) and half of patient cases will receive MBCT added to the usual medication treatment. This study is also a case-control trial, there will be matched normal controls compared with patient cases through a range of psychological scales and electroencephalogram.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
The study is designed as a prospective, assessor-blinded, randomized-control, case-control clinical trial with 70 MDD cases and 35 matched normal controls.After signed the Informed consents, MDD cases will be assigned to two groups randomly by the table generated by Microsoft Excel 2010 to ensure the random distribution between groups. The group of each patient will be allotted by the research coordinator so that evaluators will be blind about it, and patients will be asked to not mention the intervention conditions to evaluators.
As the research tools, a range of self-rating scales, other-rating scales and behavioral tests and EEG will be mainly applied to assess clinical symptoms and brain state of participants at baseline (week 0), during the intervention (week 2, 4 and 6), at the end of the intervention (week 8), and during the maintenance phase (week 12, 20 and 32).
After 8-week intervention, all of the participants including MDD cases and normal controls will enter the follow-up. Participants of medication group will continue their treatment options without changing the types and doses of medication compared with what they used in the intervention period. MBCT group is the same that participants will maintain their medication treatment and practice MBCT exercises at home.
Studietype
Inschrijving (Verwacht)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Shanghai
-
Shanghai, Shanghai, China, 200030
- Werving
- Shanghai Mental Health Center
-
Contact:
- Jianyin Qiu, Senior
- Telefoonnummer: 13524376330
- E-mail: jianyin_qiu@163.com
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion criteria for patient cases:
- Male or female, age between 18-55 years.
- Junior/middle school education or above.
- Meet the DSM- IV diagnosis of MDD by the evaluation of Chinese version of M.I.N.I. and the clinical diagnosis of one associate chief and above psychiatrist.
- HAMD24 score ≥ 8.
- Have not yet accepted psychiatric medication, or had received irregular medication treatment and had discontinued it for 8 weeks.
- Have enough visual and acoustic ability to complete the inspection required for the study.
- Each patient should be willing to participate in this study, he/she and his/her guardian must sign the informed consent form after understanding the nature of this study.
Inclusion criteria for normal controls:
- Healthy population matched patient cases in age, sex and education; Male or female; age between 18-55 years; Junior/middle school education or above.
- Excluded the possibility of mental disorders by the evaluation of Chinese version of M.I.N.I. and the psychiatric interview of one associate chief and above psychiatrist.
- HAMD24 score < 8; HAMA score < 7.
- No psychotropic drug history.
- No history of two lines of three generations of mental disorders.
- Have enough visual and acoustic ability to complete the inspection required for the study.
- Each patient should be willing to participate in this study, he/she and his/her guardian must sign the informed consent form after understanding the nature of this study.
Exclusion criteria for patient cases:
- Meet DSM-IV Axis I disorder diagnostic criteria for other psychiatric disorders.
- Have severe depression symptoms (HAMD24 score > 35), psychotic symptoms, negative self-concept or a risk of suicide.
- Persons with severe physical disease or central nervous system disease, and with substance abuse.
- Pregnancy or ready to be pregnant and lactating women.
- Had previously received systematic MBCT intervention, with no significant effect.
Exclusion criteria for normal controls:
- Have negative self-concept or a risk of suicide.
- Persons with severe physical disease or central nervous system disease, and with substance abuse.
- Pregnancy or ready to be pregnant and lactating women.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
---|---|
Experimenteel: Mindfulness-based Cognitive Therapy
MBCT group is a treatment group used mindfulness- based cognitive therapy added to the usual medication treatment, and guided by two therapists for 8 sessions.
Every group of 6 people can form a closed structural group.
Each session lasts 2 hours once a week, and has daily homework assignments.
|
Patients participating in the experimental group will receive the MBCT intervention besides the usual medication treatment.
The intervention is implemented by the manual adapted from the MBCT for Depression (Segal et al. 2013).
The modified version of the program has the same structure with the original manual combined the mindfulness training and the cognitive elements from CBT, but the content is more suitable for the Chinese.
The instructors in this study are trained and certificated psychiatrists and psychotherapists with rich experience of working with MDD, and they will receive a weekly supervision conducted by a senior supervisor.
Both of the MBCT group and the medication group will receive the medication treatment.
The initial dose conforms the drug instructions, the dosage can be adjusted once a week, and the maximum dosage should not exceed the maximum amount by the instructions.
MDD patients with sleep disorders can use drugs combined with benzodiazepine drugs, but not continuing for more than two weeks; while other psychotropic drugs are not allowed.
All of the drugs used in this study are usual clinical drugs with good security, the common adverse reactions include nausea, dry mouth, constipation, diarrhea, indigestion, dizziness, drowsiness, fatigue, sweating, heart palpitations, delayed ejaculation in male, increasing blood aminotransferase without symptoms occasionally and so on.
|
Actieve vergelijker: Medication
Medication group is a control group that can choose to use the serotonin reuptake inhibitors (SSRIs) approved by China food and Drug Administration (SFDA) for the treatment of depression (fluoxetine, paroxetine, fluvoxamine, sertraline, citalopram and escitalopram).
|
Both of the MBCT group and the medication group will receive the medication treatment.
The initial dose conforms the drug instructions, the dosage can be adjusted once a week, and the maximum dosage should not exceed the maximum amount by the instructions.
MDD patients with sleep disorders can use drugs combined with benzodiazepine drugs, but not continuing for more than two weeks; while other psychotropic drugs are not allowed.
All of the drugs used in this study are usual clinical drugs with good security, the common adverse reactions include nausea, dry mouth, constipation, diarrhea, indigestion, dizziness, drowsiness, fatigue, sweating, heart palpitations, delayed ejaculation in male, increasing blood aminotransferase without symptoms occasionally and so on.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Change of Hamilton Depression Scale-24 from baseline to 32 weeks
Tijdsspanne: baseline (week 0), during the treatment (week 2, 4, 6), end of treatment (week 8), and during the maintenance phase (weeks 12, 20 and 32)
|
The Hamilton Depression Scale-24 (HAMD-24) is the most common other-rating scale to measure the severity of depression symptoms for adult.
It is a clinical instrument with good validity and reliability, and most of the 24 items weighted from 0 to 4.
|
baseline (week 0), during the treatment (week 2, 4, 6), end of treatment (week 8), and during the maintenance phase (weeks 12, 20 and 32)
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Change of Hamilton Anxiety Scale from baseline to 32 weeks
Tijdsspanne: baseline (week 0), during the treatment (week 2, 4, 6), end of treatment (week 8), and during the maintenance phase (weeks 12, 20 and 32)
|
The Hamilton Anxiety Scale (HAMA) is a common clinician-administered scale to measure the state of anxiety among adults with anxiety symptoms.
There are 14 items of the 5-point rated scale.
|
baseline (week 0), during the treatment (week 2, 4, 6), end of treatment (week 8), and during the maintenance phase (weeks 12, 20 and 32)
|
Change of Self Compassion Scale from baseline to 32 weeks
Tijdsspanne: baseline (week 0), during the treatment (week 2, 4, 6), end of treatment (week 8), and during the maintenance phase (weeks 12, 20 and 32)
|
The Self Compassion Scale (SCS) is proved to be an instrument featured good characteristics for reliability and validity.
There are 26 items divided into 6 Subscales (out of 5 points from almost never to almost always), including self-kindness, self-judgment, common humanity, isolation, mindfulness and over-identification.
|
baseline (week 0), during the treatment (week 2, 4, 6), end of treatment (week 8), and during the maintenance phase (weeks 12, 20 and 32)
|
Medewerkers en onderzoekers
Sponsor
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Verwacht)
Studie voltooiing (Verwacht)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- MBCT2018
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Ernstige depressieve stoornis
-
University of HoustonOnbekend
-
New York City Health and Hospitals CorporationBeëindigdGlaucoom | Ziekte van het netvlies | Visuele Pathway DisorderVerenigde Staten
-
Air Force Military Medical University, ChinaVoltooidEffect van cap-geassisteerde esophagogastroduodenoscopie op observatie van majeure duodenale papillaObservatie van Major Duodenal Papilla (MDP)China
-
Neuro-Eye Diagnostic Systems, LLCNeuro-ophthalmology of Texas PLLCAanmelden op uitnodigingMacula ziekte | Visuele Pathway Disorder | Ziekte van de oogzenuwVerenigde Staten
-
CorrectSequence Therapeutics Co., LtdWervingBèta-thalassemie MajorChina
-
First Affiliated Hospital of Guangxi Medical UniversityOnbekend
-
bluebird bioVoltooidSikkelcelziekte | Bèta-thalassemie MajorFrankrijk
-
Memorial Sloan Kettering Cancer CenterActief, niet wervendBevestigde diagnose van ß-thalassemie MajorVerenigde Staten
-
BGI-researchShenzhen Children's HospitalNog niet aan het werven
-
Aghia Sophia Children's Hospital of AthensOnbekendAsplenie | β-thalassemie MajorGriekenland
Klinische onderzoeken op Mindfulness-based Cognitive Therapy
-
NYU Langone HealthVoltooidHartinfarct | Cerebraal Vasculair Accident (CVA)Verenigde Staten
-
Universitat Jaume IEuropean Social Fund; Generalitat ValencianaVoltooidMedeleven | Geestelijke gezondheid Welzijn 1Spanje
-
Stanford UniversityNational Institutes of Health (NIH)VoltooidAnorexia nervosaVerenigde Staten
-
University of New MexicoVoltooidChronische pijn | Problematisch gebruik van opioïdenVerenigde Staten